BACKGROUND: Fatty acid metabolites play a key role in numerous physiological and pathological processes. A rapid liquid chromatography-mass spectrometry assay for the simultaneous determination of prostanoids, isoprostane and lipoxygenase (LOX) derived fatty acid metabolites in a small biological sample of only 20 microL was developed. METHODS: Human plasma samples were applied to a filter spot, extracted without prior derivatization and analyzed within 13 min. Detection of metabolites was performed on a triple quadrupole mass spectrometer in negative multiple-reaction monitoring detection mode. Application of this assay to various biological matrices was performed. RESULTS: The validated assay was linear over the concentration range of 5-500 nmol/L for prostanoids and isoprostane, 50-5000 nmol/L for LOX-derived metabolites and 400-40,000 nmol/L for fatty acids. Limits of quantitation were 0.4-233 nmol/L, depending on the metabolite. Plasma samples from diabetic patients and controls showed significant increases in (+/-)9-HODE and 15(S)-HETE with p-values of 0.019 and 0.024, respectively. CONCLUSIONS: The small amount of 20 microL sample volume used in this assay and the demonstrated application to various sample types makes it an ideal routine analysis method for fatty acid metabolites. The resulting values for LOX-derived metabolites in diabetes mellitus type 2 samples support earlier findings about the role of lipid oxidation products in diabetes.
BACKGROUND:Fatty acid metabolites play a key role in numerous physiological and pathological processes. A rapid liquid chromatography-mass spectrometry assay for the simultaneous determination of prostanoids, isoprostane and lipoxygenase (LOX) derived fatty acid metabolites in a small biological sample of only 20 microL was developed. METHODS:Human plasma samples were applied to a filter spot, extracted without prior derivatization and analyzed within 13 min. Detection of metabolites was performed on a triple quadrupole mass spectrometer in negative multiple-reaction monitoring detection mode. Application of this assay to various biological matrices was performed. RESULTS: The validated assay was linear over the concentration range of 5-500 nmol/L for prostanoids and isoprostane, 50-5000 nmol/L for LOX-derived metabolites and 400-40,000 nmol/L for fatty acids. Limits of quantitation were 0.4-233 nmol/L, depending on the metabolite. Plasma samples from diabeticpatients and controls showed significant increases in (+/-)9-HODE and 15(S)-HETE with p-values of 0.019 and 0.024, respectively. CONCLUSIONS: The small amount of 20 microL sample volume used in this assay and the demonstrated application to various sample types makes it an ideal routine analysis method for fatty acid metabolites. The resulting values for LOX-derived metabolites in diabetes mellitus type 2 samples support earlier findings about the role of lipid oxidation products in diabetes.
Authors: Jafar Sadik B Shaik; Tricia M Miller; Steven H Graham; Mioara D Manole; Samuel M Poloyac Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2013-11-25 Impact factor: 3.205
Authors: Maren C Podszun; Joon-Yong Chung; Kris Ylaya; David E Kleiner; Stephen M Hewitt; Yaron Rotman Journal: J Histochem Cytochem Date: 2020-09 Impact factor: 2.479
Authors: Lucie Aumailley; Marie Julie Dubois; Tracy A Brennan; Chantal Garand; Eric R Paquet; Robert J Pignolo; André Marette; Michel Lebel Journal: FASEB J Date: 2018-02-08 Impact factor: 5.191
Authors: Rui Wang-Sattler; Yao Yu; Kirstin Mittelstrass; Eva Lattka; Elisabeth Altmaier; Christian Gieger; Karl H Ladwig; Norbert Dahmen; Klaus M Weinberger; Pei Hao; Lei Liu; Yixue Li; H-Erich Wichmann; Jerzy Adamski; Karsten Suhre; Thomas Illig Journal: PLoS One Date: 2008-12-05 Impact factor: 3.240
Authors: Christian Gieger; Ludwig Geistlinger; Elisabeth Altmaier; Martin Hrabé de Angelis; Florian Kronenberg; Thomas Meitinger; Hans-Werner Mewes; H-Erich Wichmann; Klaus M Weinberger; Jerzy Adamski; Thomas Illig; Karsten Suhre Journal: PLoS Genet Date: 2008-11-28 Impact factor: 5.917